Neuroprotective effect of epigallocatechin-3-gallate in a mouse model of chronic glaucoma

Neuroscience Letters

Volumn 600, Issue , 2015, Pages 132-136

  Shen, Ceying ^a   Chen, Lanlan ^a   Jiang, Libin ^a   Lai, Timothy Y Y ^b,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c 2010 Retina and Macula Centre   (Hong Kong)

Author keywords

Epigallocatechin 3 gallate; Glaucoma; High intraocular pressure; Neuroprotection; Retinal ganglion cells

Indexed keywords

EPIGALLOCATECHIN GALLATE; CATECHIN; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GLAUCOMA; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; DRUG EFFECTS; ORAL DRUG ADMINISTRATION; PATHOLOGY; PATHOPHYSIOLOGY;

ADMINISTRATION, ORAL; ANIMALS; CATECHIN; CELL SURVIVAL; CHRONIC DISEASE; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MICE, INBRED C57BL; NEUROPROTECTIVE AGENTS; RETINAL GANGLION CELLS;

EID: 84934974487     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2015.06.002     Document Type: Article

References (24)

1. Whitmore A.V., Libby R.T., John S.W. Glaucoma: thinking in new ways-a role for autonomous axonal self-destruction and other compartmentalised processes. Prog. Retin. Eye Res. 2005, 24:639-662.
2. Foster P.J. The epidemiology of primary angle closure and associated glaucomatous optic neuropathy. Semin. Ophthalmol. 2002, 17:50-58.
3. Chang E.E., Goldberg J.L. Glaucoma 2.0: neuroprotection neuroregeneration, neuroenhancement. Ophthalmology 2012, 119:979-986.
4. Cabrera C., Artacho R., Gimenez R. Beneficial effects of green tea - a review. J. Am. Coll. Nutr. 2006, 25:79-99.
5. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (egcg): mechanisms, perspectives and clinical applications. Biochem, Pharmacol. 2011, 82:1807-1821.
6. Tedeschi E., Suzuki H., Menegazzi M. Antiinflammatory action of egcg the main component of green tea, through STAT-1 inhibition. Ann. N. Y. Acad. Sci. 2002, 973:435-437.
7. Chen J.H., Tipoe G.L., Liong E.C., So H.S., Leung K.M., Tom W.M., Fung P.C., Nanji A.A. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am. J. Clin. Nutr. 2004, 80:742-751.
8. Lorenz M., Wessler S., Follmann E., Michaelis W., Dusterhoft T., Baumann G., Stangi K., Stangi V. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J. Biol. Chem. 2004, 279:6190-6195.
9. Mandel S., Weinreb O., Amit T., Youdin M.B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem. 2004, 88:1555-1569.
10. Mandel S.A., Avramovich-Tirosh Y., Reznichenko L., Zheng H., Weinreb O., Amit T., Youdim M.B. Multifunctional activities of green tea catechins in neuroprotection. modulation of cell survival genes iron-dependent oxidative stress and PKC signalling pathway. Neurosignals 2005, 14:46-60.
11. Xie J., Jiang L.B., Zhang T., Jin Y., Yang D., Chen F. Neuroprotective effects of epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats. Neurosci. Lett. 2010, 479:26-30.
12. Chen F., Jiang L.B., Shen C.Y., Wan H., Xu L., Wang N., Jonas J.B. Neuroprotective effect of epigallocatechin-3-gallate against N-methyl-D-aspartate-induced excitotoxicity in the adult rat retina. Acta. Ophthalmol. 2012, 90:e609-615.
13. Saeki T., Aihara M., Ohashi M., Araie M. The efficacy of tonolab in detecting physiological and pharmacological changes of mouse intraocular pressure - comparison with TonoPen and microneedle manometery. Curr. Eye. Res. 2008, 33:247-252.
14. Sappington R.M., Carlson B.J., Crish S.D., Calkins D.J. The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice. Invest. Ophthalmol. Vis. Sci. 2010, 51:207-216.
15. Chen H., Wei X., Cho K.S., Chen G., Sappington R., Calkins D.J., Chen D.F. Optic neuropathy due to microbead - induced elevated intraocular pressure in the mouse. Invest. Ophthalmol. Vis. Sci. 2011, 52:36-44.
16. K.Chiu W.M., Lau S.C., Yeung R.C., Chang K.F.So Retrograde labeling of retinal ganglion cells by application of fluoro-gold on the surface of superior colliculus. J. Vis. Exp. 2008, 16. pii: 819.
17. Quigley H.A., McKinnon S.J., Zack D.J., Pease M.E., Kerrigan-Baumrind L.A., Kerrigan D.F., Mitchell R.S. Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest. Ophthalmol. Vis. Sci. 2000, 41:3460-3466.
18. Buckingham B.P., Inman D.M., Lambert W., Oglesby E., Calkins D.J., Steele M.R., Vetter M.L., Marsh-Armstrong N., Horner P.J. Progressive ganglion cell degeneration precedes neuronal loss in a mouse model of glaucoma. J. Neurosci. 2008, 28:2735-2744.
19. Fitzgerald M., Bartlett C.A., Evill L., Rodger J., Harvey A.R., Dunlop S.A. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine. Exp. Neurol. 2009, 216:219-230.
20. Sharma R.K., Netland P.A. Early born lineage of retinal neurons express class III beta-tubulin isotype. Brain Res. 2007, 1176:11-17.
21. Danias J., Lee K.C., Zamora M.F., Chen B., Shen F., Filippopoulos T., Su Y., Goldblum D., Podos S.M., Mittag T. Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with rgc loss in aging C57/BL6 mice. Invest. Ophthalmol. Vis. Sci. 2003, 44:5151-5162.
22. Kang T.H., Lee J.H., Song C.K., Han H.D., Shin B.C., Pai S.I., Hung C.F., Trimble C., Lim J.S., Kim T.W., Wu T.C. Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by dna vaccination. Cancer Res. 2007, 67:802-811.
23. Lin L.C., Wang M.N., Tseng T.Y., Sung J.S., Tsai T.H. Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J. Agric. Food Chem. 2007, 55:1517-1524.
24. Falsini B., Marangoni D., Salgarello T., Stifano G., Montrone L., Di Landro S., Guccione L., Balestrazzi E., Colotto A. Effect of epigallocatechin-gallate on inner retinal function in ocular hypertension and glaucoma: a short-term study by pattern electroretinogram. Graefes. Arch. Clin. Exp. Ophthalmol. 2009, 247:1223-1233.